FDA recall D-0921-2017

Product

Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg, packaged in a) 30-count bottles (NDC 52343-132-30) and b) 90-count bottles (NDC 52343-132-90), Rx only, Distributed by: Lucid Pharma LLC, 2 Tower Center Blvd, Suite-1101-B, East Brunswick, NJ 08816 USA.

Reason for recall

Failed Tablet/Capsules Specifications: pharmacists complaints for bottles containing melted capsules.

Distribution

Nationwide in the USA

Key facts

Status

Terminated

Initiation date

2017-06-01

Report date

2017-06-28

Termination date

2019-09-25

Voluntary/Mandated

Voluntary: Firm initiated

Location

East Brunswick, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0921-2017